Norris Perne & French’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-161,612
Closed -$11.5M 140
2018
Q3
$11.5M Sell
161,612
-11,383
-7% -$724K 1.5% 27
2018
Q2
$9.02M Sell
172,995
-2,129
-1% -$112K 1.31% 35
2018
Q1
$9.14M Buy
175,124
+17,136
+11% +$869K 1.33% 33
2017
Q4
$9.24M Sell
157,988
-7,231
-4% -$410K 1.34% 31
2017
Q3
$9.16M Buy
165,219
+51,559
+45% +$3.41M 1.43% 24
2017
Q2
$8.74M Buy
113,660
+42,625
+60% +$3.19M 1.47% 22
2017
Q1
$5.3M Buy
71,035
+4,475
+7% +$325K 0.99% 47
2016
Q4
$4.48M Buy
66,560
+5,775
+10% +$372K 0.88% 49
2016
Q3
$4.05M Buy
+60,785
New +$3.87M 0.84% 50

Other funds holding NUVA

Norris Perne & French's NUVA Position: Q4 2018 in Review

Norris Perne & French sold out of NuVasive, Inc. (NUVA) in Q4 2018, closing a stake of 161,612 shares — an estimated $11.5M sold.

Norris Perne & French first reported a position in NUVA in Q3 2016 and held it in 9 quarters. The position peaked at $11.5M in Q3 2018. 290 funds tracked by Wall St. Rank hold NUVA as of Q4 2018.

  • Norris Perne & French reported no remaining NuVasive, Inc. position as of Q4 2018 after selling out during the quarter.
  • Norris Perne & French sold 161,612 NuVasive, Inc. shares in Q4 2018, an estimated $11.5M.
  • Norris Perne & French first reported a position in NuVasive, Inc. in Q3 2016 and held it in 9 quarters.
  • Norris Perne & French's NuVasive, Inc. position peaked at $11.5M in Q3 2018.
  • 290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2018.

Based on Norris Perne & French's 13F filing for Q4 2018, filed 28 Jan 2019.